SCHEMBL177823

SCHEMBL177823

NC(=O)CS(=O)(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27685628 0.97 ALDH1A1 (0.37)
SCHEMBL178230 0.97
Ammonia Solution, Strong SCHEMBL9018978 0.97
SCHEMBL177636 0.97
SCHEMBL2348801 0.76 POLB (0.50)
SCHEMBL674966 0.73
SCHEMBL27664620 0.73 ALDH1A1 (0.39)
SCHEMBL4968468 0.72 ACP1 (0.38)
SCHEMBL20922 0.71 TDP1 (0.35)
SCHEMBL2057581 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 665 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114007689-B Polymorphs and co-crystals of a cardiac troponin activator 安进股份有限公司 2025-01-03 CN claimed
US-20230346660-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2023-11-02 US claimed
US-20230338273-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2023-10-26 US claimed
US-20230270637-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2023-08-31 US claimed
CN-116670151-A Antibacterial cyclic peptides targeting acinetobacter and other gram negative pathogens 犹他大学研究基金会 2023-08-29 CN claimed
US-20230255865-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2023-08-17 US claimed
US-11701314-B2 Processes and methods COLGATE-PALMOLIVE COMPANY (US) 2023-07-18 US claimed
EP-4188556-A1 ORAL CARE COMPOSITIONS Colgate-Palmolive Company (US) 2023-06-07 EP claimed
EP-4188312-A1 ORAL CARE COMPOSITIONS Colgate-Palmolive Company (US) 2023-06-07 EP claimed
EP-4188317-A1 ORAL CARE COMPOSITIONS Colgate-Palmolive Company (US) 2023-06-07 EP claimed
EP-0927217-A1 ANGIOGENIC INHIBITORY COMPOUNDS BIOMOLECULAR RESEARCH INSTITUTE LTD. (AU) 1999-07-07 EP claimed
WO-1998003573-A1 ANGIOGENIC INHIBITORY COMPOUNDS BIOMOLECULAR RESEARCH INSTITUTE LTD. (AU) 1998-01-29 WO claimed
EP-0765357-A4 ANTIVIRAL DENDRIMERS BIOMOLECULAR RES INST LTD (AU) 1997-07-30 EP claimed
EP-0765357-A1 ANTIVIRAL DENDRIMERS BIOMOLECULAR RESEARCH INSTITUTE LTD. (AU) 1997-04-02 EP claimed
WO-1995034595-A1 ANTIVIRAL DENDRIMERS BIOMOLECULAR RESEARCH INSTITUTE LTD. (AU) 1995-12-21 WO claimed
US-5302293-A Using a water soluble polymer containing pendant N-sulfoalkylene or -phenylene groups based on acrylic acid and/or amide groups; stabilizing suspensions; arctic region NALCO CHEMICAL COMPANY (US) 1994-04-12 US claimed
EP-0261079-B1 REACTIVE DYES, THEIR PREPARATION AND THEIR USE CIBA-GEIGY AG (CH) 1991-10-16 EP claimed
US-4845203-A FOR CELLULOSE FIBERS CIBA-GEIGY CORPORATION (US) 1989-07-04 US claimed
US-4124704-A ANTIMICROBIAL RIKER LABORATORIES, INC. (US) 1978-11-07 US claimed
US-4067993-A Antimicrobial 2-nitro-3-phenylbenzofurancarboxylic acids RIKER LABORATORIES, INC. (US) 1978-01-10 US claimed